Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: DelveInsight | PRODUCT CODE: 1147344

Cover Image

PUBLISHER: DelveInsight | PRODUCT CODE: 1147344

Chronic Smell and Flavor Loss - Epidemiology Forecast-2032

PUBLISHED:
PAGES: 70 Pages
DELIVERY TIME: 1-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (2-3 user license)
USD 5925
PDF (Site License)
USD 7900
PDF (Global License)
USD 11850

Add to Cart

Description

Table of Contents

List of Tables

DelveInsight's 'Chronic smell and flavor loss - Epidemiology Forecast-2032' report delivers an in-depth understanding of Chronic smell and flavor loss historical and forecasted epidemiology in the United States, the EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic smell and flavor loss Disease Understanding

Disorders of smell and taste challenge the ability to consume safe and healthy diets as well as enjoy eating and food-related behaviors. These disorders impair the ability to sense warning odors in foods and the environment and hinder the quality of life (QoL)-related to social interactions, eating, and feelings of well-being. These are not life-threatening and usually represent significant underlying diseases; therefore, they are often overlooked by the medical community.

Chronic smell and flavor loss Epidemiology

The Chronic smell and flavor loss epidemiology report provides insights into the historical and incident patient pool, along with the forecasted trend for all seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings

The total prevalent cases of Chronic smell and flavor loss patients in the 7MM will increase during the study period, i.e., 2019-2032.

The disease epidemiology covered in the report provides historical as well as forecasted Chronic smell and flavor loss symptoms epidemiology segmented as the total prevalent cases of chronic smell and flavor loss, total diagnosed cases of chronic smell and flavor loss (including COVID-19 patients), age-specific cases of chronic smell and flavor loss, and etiology-specific cases of Chronic smell and flavor loss. The report includes the prevalent cases scenario of Chronic smell and flavor loss in the 7MM covering the United States, the EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.

Country-wise Chronic smell and flavor loss Epidemiology

The epidemiology segment also provides the chronic smell and flavor loss epidemiology data and findings across the United States, the EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The prevalent cases of Chronic smell and flavor loss associated in the 7MM countries were around 214 million in 2021.

As per the estimates, the United States has the highest number of prevalent cases of Chronic smell and flavor loss in 2021.

Among the EU5 countries, Germany had the highest number of prevalent cases of Chronic smell and flavor loss, followed by Italy in 2021. On the other hand, Spain had the lowest number of prevalent cases, with nearly 15.5 million cases in 2021.

Scope of the Report:

  • The Chronic smell and flavor loss report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
  • The Chronic smell and flavor loss Epidemiology Report and Model provide an overview of Chronic smell and flavor loss's risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, the UK, and Japan).
  • The report provides insight into Chronic smell and flavor loss's historical and forecasted patient pool in seven major markets covering the United States, the EU5 (Germany, Spain, France, Italy, the UK), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Chronic smell and flavor loss.
  • The report provides the segmentation of chronic smell and flavor loss epidemiology by the prevalent cases of chronic smell and flavor loss in the 7MM.
  • The report provides the chronic smell and flavor loss epidemiology segmentation by severity-specific cases of chronic smell and flavor loss in the 7MM.
  • The report provides the chronic smell and flavor loss epidemiology segmentation by age-specific cases of chronic smell and flavor loss in the 7MM.
  • The report provides the chronic smell and flavor loss epidemiology segmentation by cause-specific cases of chronic smell and flavor loss in the 7MM.

Report Highlights:

  • 11-year Forecast of Chronic smell and flavor loss epidemiology
  • 7MM Coverage
  • Prevalent Cases of Chronic smell and flavor loss
  • Diagnosed cases of Chronic smell and flavor loss
  • Age-specific Cases of Chronic smell and flavor loss
  • Gender-specific cases of Chronic smell and flavor loss
  • Etiology-specific cases of Chronic smell and flavor loss

KOL Views

We interview KOLs, and SMEs' opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.

Key Questions Answered:

  • What are the major factors that will drive the change in the patient population in chronic smell and flavor loss during the forecast period (2019-2032)?
  • What are the key findings of chronic smell and flavor loss epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2019-2032)?
  • What would be the total number of chronic smell and flavor loss patients across the 7MM during the forecast period (2019-2032)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
  • At what CAGR the patient population is expected to grow in the 7MM during the forecast period (2019-2032)?
  • What are the disease risks, burdens, and unmet needs of the chronic smell and flavor loss market?
  • What are the current treatment patterns for chronic smell and flavor loss?

Reasons to buy:

The Chronic smell and flavor loss epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global chronic smell and flavor loss market.
  • Quantify patient populations in the global chronic smell and flavor loss market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for chronic smell and flavor loss therapeutics in each market covered.
  • Understand the magnitude of the chronic smell and flavor loss population by its prevalence.
  • Understand the magnitude of the chronic smell and flavor loss population by its severity-specific cases.
  • Understand the magnitude of the chronic smell and flavor loss population by its age-specific cases.
  • Understand the magnitude of the chronic smell and flavor loss population by its cause-specific cases.
  • The Chronic smell and flavor loss Epidemiology Report and model were written and developed by Master's and Ph.D. level epidemiologists.
  • The Chronic smell and flavor loss Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered:

  • The United States
  • The EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2019-2032.

Show more
Product Code: DIEI1732

Table of Contents

1. Key Insights

2. Report Introduction

3. Chronic Smell and Flavor Loss Market Overview at a Glance

  • 3.1. Market Share (%) Distribution of Chronic Smell and Flavor Loss in 2019
  • 3.2. Market Share (%) Distribution of Chronic Smell and Flavor Loss in 2032

4. Executive Summary of Chronic Smell and Flavor Loss

5. Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Classification
    • 5.2.1. Smell disorders
    • 5.2.2. Taste disorders
  • 5.3. Signs and Symptoms
    • 5.3.1. Anosmia or hyposmia
    • 5.3.2. Dysgeusia
    • 5.3.3. Ageusia
  • 5.4. Etiology and Risk Factors
    • 5.4.1. Etiology of taste disorders
    • 5.4.2. Etiology of OD
  • 5.5. Physiology and Pathogenesis
    • 5.5.1. Sense of olfaction and pathophysiology of olfactory disorders
    • 5.5.2. Sense of gustation and pathophysiology of gustatory disorders
  • 5.6. Smell and Taste Disorders in COVID-19
  • 5.7. Diagnosis of Chronic Smell and Flavor Loss
    • 5.7.1. Physical examination and self-assessment tools
    • 5.7.2. Psychophysical assessment
    • 5.7.3. Imaging tests
    • 5.7.4. Other tests
  • 5.8. Differential Diagnosis
    • 5.8.1. Ageusia
    • 5.8.2. Anosmia
  • 5.9. Treatment
    • 5.9.1. Treatment of olfactory disorders
    • 5.9.2. Treatment of taste disorders
  • 5.10. Clinical Practice Guidelines
    • 5.10.1. Clinical Practice Guidelines for the Management of OD by the Japanese Rhinologic Society
    • 5.10.2. Management of New-Onset Loss of Sense of Smell during the COVID-19 Pandemic - BRS Consensus Guidelines
    • 5.10.3. ENT referral
    • 5.10.4. Investigations
    • 5.10.5. Management

6. Epidemiology and Patient Population

  • 6.1. Total Prevalent Population of Chronic Smell and Flavor Loss in the 7MM
  • 6.2. Key Findings
  • 6.3. Assumptions and Rationale
  • 6.4. The United States
    • 6.4.1. Total Prevalent Cases of Chronic Smell and Flavor Loss in the United States
    • 6.4.2. Prevalence of Chronic Smell and Flavor Impairment
    • 6.4.3. Prevalence of Smell Impairment
    • 6.4.4. Prevalence of Flavor Impairment
    • 6.4.5. Total Diagnosed Cases of Chronic Smell and Flavor Loss in the United States
    • 6.4.6. Diagnosed prevalent cases
    • 6.4.7. Diagnosed prevalent cases (excluding COVID-19)
    • 6.4.8. Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States
    • 6.4.9. Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States
    • 6.4.10. Etiology-specific (excluding COVID-19 patients) Cases of Chronic Smell and Flavor Loss in the United States
  • 6.5. The EU5
    • 6.5.1. Total Prevalent Cases of Chronic Smell and Flavor Loss in the EU5
    • 6.5.2. Prevalence of Chronic Smell and Flavor Impairment
    • 6.5.3. Prevalence of Smell Impairment
    • 6.5.4. Prevalence of Flavor Impairment
    • 6.5.5. Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in the EU5
    • 6.5.6. Diagnosed Prevalent Cases
    • 6.5.7. Diagnosed prevalent cases (excluding COVID-19 patients)
    • 6.5.8. Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5
    • 6.5.9. Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5
    • 6.5.10. Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5
  • 6.6. Japan
    • 6.6.1. Total Prevalent Cases of Chronic Smell and Flavor Loss in Japan
    • 6.6.2. Prevalence of Chronic Smell and Flavor Loss
    • 6.6.3. Prevalence of Smell Impairment
    • 6.6.4. Prevalence of Flavor Impairment
    • 6.6.5. Total Diagnosed Cases of Chronic Smell and Flavor Loss in Japan
    • 6.6.6. Diagnosed Prevalent Cases
    • 6.6.7. Diagnosed Prevalent Cases (excluding COVID-19 patients)
    • 6.6.8. Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan
    • 6.6.9. Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan
    • 6.6.10. Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan

7. KOL Views

8. Acronyms and Abbreviations

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Show more
Product Code: DIEI1732

List of Tables

  • Table 1: Summary of Chronic Smell and Flavor Loss, Market, Epidemiology, and Key Events (2019-2032)
  • Table 2: ODs
  • Table 3: Causes of Olfactory Disturbance
  • Table 4: Total Prevalent Population of Chronic Smell and Flavor Loss in the 7MM, in 000's (2019-2032)
  • Table 5: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the United States, in 000's (2019-2032)
  • Table 6: Total Prevalent Cases of Chronic Smell Loss in the United States, in 000's (2019-2032)
  • Table 7: Total Prevalent Cases of Chronic Flavor Loss in the United States, in 000's (2019-2032)
  • Table 8: Total Diagnosed Prevalent cases of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Table 9: Total Diagnosed Prevalent cases (excluding COVID-19) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Table 10: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Table 11: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Table 12: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Table 13: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the EU5 , in 000's (2019-2032)
  • Table 14: Total Prevalent Cases of Chronic Smell Loss in the EU5, in 000's (2019-2032)
  • Table 15: Total Prevalent Cases of Chronic Flavor Loss in the EU5, in 000's (2019-2032)
  • Table 16: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Table 17:Diagnosed Prevalent Cases (excluding COVID-19 patients) in the EU5, in 000's (2019-2032)
  • Table 18: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Table 19: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Table 20: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Table 21: Total Prevalent Cases of Chronic Smell Loss in Japan, in 000's (2019-2032)
  • Table 22: Total Prevalent Cases of Chronic Smell Loss in Japan, in 000's (2019-2032)
  • Table 23: Total Prevalent Cases of Chronic Flavor Loss in Japan, in 000's (2019-2032)
  • Table 24: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Table 25: Total Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Table 26: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Table 27: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Table 28: Etiology-specific Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)

List of Figures

  • Figure 1: Taste Disorders
  • Figure 2: Signs and Symptoms of Anosmia/hyposmia
  • Figure 3: Causes of Taste Disorders
  • Figure 4: Anatomy of Taste and Olfaction
  • Figure 5: Possible Pathogenesis of Olfactory Disorders in COVID-19
  • Figure 6: Treatment Algorithm of Postviral OD
  • Figure 7: Total Prevalent Population of Chronic Smell and Flavor Loss in the 7MM, in 000's (2019-2032)
  • Figure 8: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the United States, in 000's (2019-2032)
  • Figure 9: Total Prevalent Cases of Chronic Smell Loss in the United States, in 000's (2019-2032)
  • Figure 10: Total Prevalent Cases of Chronic Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 11: Total Diagnosed Prevalent cases of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 12: Total Diagnosed Prevalent cases (excluding COVID-19) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 13: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 14: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 15: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the United States, in 000's (2019-2032)
  • Figure 16: Total Prevalent Cases of Chronic Smell and Flavor Impairment in the EU5, in 000's (2019-2032)
  • Figure 17: Total Prevalent Cases of Chronic Smell Loss in the EU5, in 000's (2019-2032)
  • Figure 18: Total Prevalent Cases of Chronic Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 19: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 20: Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 21: Gender-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 22: Age-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 23: Etiology-specific Diagnosed Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in the EU5, in 000's (2019-2032)
  • Figure 24: Total Prevalent Cases of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Figure 25: Total Prevalent Cases of Chronic Smell Loss in Japan, in 000's (2019-2032)
  • Figure 26: Total Prevalent Cases of Chronic Flavor Loss in Japan, in 000's (2019-2032)
  • Figure 27: Total Diagnosed Prevalent Cases of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
  • Figure 28: Total Diagnosed Prevalent Cases (excluding COVID-19 patients) of Chronic Smell and Flavor Loss in Japan, in 000's (2019-2032)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!